ArticleFrontiers in neurology2025
The genotypic and family characteristics and clinical intervention of neurofibromatosis type 1 gene are associated with dystrophic scoliosis by whole-exome sequencing.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neurofibromin in bone disease: Mechanisms and therapeutic implications (Review).International journal of molecular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To investigate the genotypic and family genetic characteristics of neurofibromatosis type 1 (NF-1) patients associated with dystrophic scoliosis and to further evaluate the clinical efficiency of surgical intervention to these patients. Methods: A total of seven NF-1 patients with dystrophic scoliosis and their 11 immediate relatives were included in this study who visited The Affiliated Hospital of Qingdao University spinal surgery department from January 2020 to December 2022. The outcomes were summarized by investigating the clinical and imaging parameters before and after the treatment. Whole-exome sequencing (WES) was conducted to analyze the genotypic and family genetic characteristics of all patients and their families. Results: Among the seven patients, six patients underwent surgical treatment after follow-up. Compared to preoperative Cobb angle, the maximum postoperative correction rate was 85.3%. We identified eight pathogenic variants in the NF-1 gene. The variants c.c4084T and c. T4445C were located in the GAP-related domain, and the variant c. G1885A was shared by patient 3 and his diseased sibling. In the family of patient 3, variant c. G1885A was detected in both neurofibromatosis patients. The rs112819846 exhibited the most pronounced frequency disparity, whereas rs2916067 and rs80221306 were found in all patients. Conclusion: In this cohort study, NF-1 patients with dystrophic scoliosis predominantly presented with upper thoracic involvement, and surgical correction achieved a maximum postoperative Cobb angle correction rate of 85.3% without loss of correction during follow-up. The c. G1885A variant in the NF-1 gene may influence the phenotypic severity of the disease, while rs112819846, rs2916067, and rs80221306 may represent disease-relevant pathogenic variants of NF-1 patients with dystrophic scoliosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.